Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-3,805
Closed -$929K 1973
2024
Q3
$929K Sell
3,805
-4,761
-56% -$1.06M 0.05% 268
2024
Q2
$1.64M Buy
+8,566
New +$1.74M 0.11% 178
2024
Q1
Sell
-7,519
Closed -$1.29M 1984
2023
Q4
$1.29M Buy
+7,519
New +$1.16M 0.1% 167
2023
Q3
Sell
-2,163
Closed -$472K 1795
2023
Q2
$472K Buy
+2,163
New +$482K 0.04% 420
2023
Q1
Sell
-7,222
Closed -$1.5M 2012
2022
Q4
$1.5M Buy
+7,222
New +$1.59M 0.2% 94
2022
Q3
Sell
-6,825
Closed -$1.43M 2156
2022
Q2
$1.43M Buy
+6,825
New +$1.45M 0.12% 147
2021
Q3
Sell
-885
Closed -$218K 1889
2021
Q2
$218K Sell
885
-725
-45% -$152K 0.02% 941
2021
Q1
$312K Buy
+1,610
New +$323K 0.02% 792
2020
Q4
Sell
-1,821
Closed -$312K 1738
2020
Q3
$312K Buy
+1,821
New +$336K 0.05% 425
2018
Q3
Sell
-5,029
Closed -$521K 2076
2018
Q2
$521K Buy
5,029
+2,260
+82% +$229K 0.03% 771
2018
Q1
$273K Buy
+2,769
New +$262K 0.01% 1127
2017
Q4
Sell
-5,162
Closed -$397K 2909
2017
Q3
$397K Buy
+5,162
New +$395K 0.02% 1118

Other funds holding RMD

Virtu Financial's RMD Position: Q4 2024 in Review

Virtu Financial sold out of ResMed (RMD) in Q4 2024, closing a stake of 3,805 shares — an estimated $929K sold.

Virtu Financial first reported a position in RMD in Q3 2017 and held it in 12 quarters. The position peaked at $1.64M in Q2 2024. 871 funds tracked by Wall St. Rank hold RMD as of Q4 2024.

  • Virtu Financial reported no remaining ResMed position as of Q4 2024 after selling out during the quarter.
  • Virtu Financial sold 3,805 ResMed shares in Q4 2024, an estimated $929K.
  • Virtu Financial first reported a position in ResMed in Q3 2017 and held it in 12 quarters.
  • Virtu Financial's ResMed position peaked at $1.64M in Q2 2024.
  • 871 funds tracked by Wall St. Rank held ResMed as of Q4 2024.

Based on Virtu Financial's 13F filing for Q4 2024, filed 11 Feb 2025.